<i>In vivo</i> generation of chimeric antigen receptor T cells using optimally retargeted and functionalized lentiviral vectors with reduced immune clearance

Kepler Mears(Broad Institute), Robert T. Manguso(Broad Institute)
bioRxiv (Cold Spring Harbor Laboratory)
April 24, 2025
10.1101/2025.04.23.645810
Cited by 2

Related Papers

An expanded universe of cancer targets
|Cell|2021|221
Mutant IDH1 inhibition induces dsDNA sensing to activate tumor immunity
|Science|2024|87
DNAJB1-PRKACA Fusion Drives Fibrolamellar Liver Cancer through Impaired SIK Signaling and CRTC2/p300-Mediated Transcriptional Reprogramming
|Cancer Discovery|2024|14
Abstract 606: Targeting the immune checkpoint PTPN2 with ABBV-CLS-484 inflames the tumor microenvironment and unleashes potent CD8+ T cell immunity
|Cancer Research|2022|8
Abstract ND06: ABBV-CLS-484: An active site PTPN2/N1 inhibitor that augments the immune response and sensitizes tumors to immune-mediated killing
|Cancer Research|2022|7